Comment on "Outcomes of Acute Pancreatitis in Lean Versus Non-lean Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) Patients: A Nationwide Analysis"

Xin Chen¹

Affiliations

Xin Chen. Dig Dis Sci. 2025.

. 2025 Aug 20.

doi: 10.1007/s10620-025-09340-0. Online ahead of print.

Xin Chen¹

¹ Department of Gastroenterology, Nantong Hospital to Nanjing University of Chinese Medicine, Nantong, 226000, Jiangsu, China. cx200102@126.com.

No abstract available

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

1. Ameyaw PA, Boateng S, Issaka Y et al. Outcomes of acute pancreatitis in lean versus non-lean metabolic dysfunction-associated steatotic liver disease (MASLD) patients: a nationwide analysis. Dig Dis Sci. 2025. https://doi.org/10.1007/s10620-025-09245-y . - DOI - PubMed
1. Wong VW. Complex interaction between visceral adiposity and metabolic dysfunction-associated steatotic liver disease. J Clin Exp Hepatol. 2025;15:102426. https://doi.org/10.1016/j.jceh.2024.102426 . - DOI - PubMed
1. Bálint ER, Fűr G, Kiss L et al. Assessment of the course of acute pancreatitis in the light of aetiology: a systematic review and meta-analysis. Sci Rep. 2020;10:17936. https://doi.org/10.1038/s41598-020-74943-8 . - DOI - PubMed - PMC
1. Harshit Kumar A, Singh Griwan M. A comparison of APACHE II, BISAP, Ranson’s score and modified CTSI in predicting the severity of acute pancreatitis based on the 2012 revised Atlanta Classification. Gastroenterol Rep (Oxf). 2018;6:127–131. https://doi.org/10.1093/gastro/gox029 . - DOI - PubMed
1. Lee SH, Choe JW, Cheon YK et al. Revised clinical practice guidelines of the korean pancreatobiliary association for acute pancreatitis. Gut Liver. 2023;17:34–48. https://doi.org/10.5009/gnl220108 . - DOI - PubMed